2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH SUSAN HALABI
Racial Disparities in Prostate Cancer Treatment and Outcomes

VIEW ALL PROSTATE CANCER VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH MICHAEL HOFMAN
Theranostic Approaches for Advanced Prostate Cancer

VIEW ALL IMAGING: PROSTATE VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH KARIM FIZAZI
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC

VIEW ALL nmCRPC VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH MATTHEW GALSKY
Combination Approaches with Immune-Checkpoint Blockade in Bladder Cancer

VIEW ALL BLADDER CANCER VIDEOS

Featured Videos

#AUA14 - Poster: Long-term efficacy and safety of repeat onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: Third interim analysis, median 2.4 years follow-up

ORLANDO, FL USA (UroToday.com) - Presented by Victor Nitti,1 Christopher Chapple,2 David Sussman,3 Sidney Radomski,4 Peter Sand,5 Steven Guard,6 Christopher Nardo,7 Jihao Zhou,8 and Karl-Dietrich Sievert9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 poster nitti oab es qol thumb

1New York University, New York, NY, USA; 2Royal Hallamshire Hospital, Sheffield, UK; 3NJ School of Osteopathic Medicine, Newark, NJ, USA; 4University of Toronto, Toronto, ON, Canada; 5University of Chicago, Chicago, IL, USA; 6Allergan, Ltd., Marlow, UK; 7Allergan, Inc., Irvine, CA, USA; 8Allergan, Inc., Bridgewater, NJ, USA; 9University of Tuebingen, Tuebingen, Germany

 

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 3 Issue 4

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe